Sort by
Medicine and Dentistry
Migraine
100%
Headache
98%
Apoplexy
96%
Neurology
89%
Meningitis
82%
Ganglioglioma
82%
Encephalitis
82%
Prevalence
63%
Biological Marker
54%
Cohort Analysis
54%
Brain Ischemia
50%
Minimally Invasive Procedure
45%
Anticonvulsant
41%
Burnout Syndrome
41%
Monoclonal Antibody
41%
Triptan
41%
Addictive Behavior
41%
Glucagon-Like Peptide-1 Agonist
41%
Glucagon Like Peptide 1
41%
Posterior Lumbar Interbody Fusion
41%
Cervical Nerve Root
41%
Spinal Hematoma
41%
Spine Fracture
41%
Primary Headache
41%
Artificial Intelligence
41%
Primary Health Care
41%
Burnout
41%
Courage
41%
Contraindication
41%
Health Care Personnel
41%
Sex Differences
41%
COVID-19
41%
Streptococcus pneumonia
41%
Pneumococcal Pneumonia
41%
Subarachnoid Hemorrhage
41%
Cerebral Vasculitis
41%
Fusobacterium nucleatum
41%
Neuroendoscopy
41%
Molecular Profiling
41%
Pterygopalatine Fossa
41%
Human Immunodeficiency Virus
41%
Flow Cytometry
41%
Cerebrospinal Fluid Flow
41%
CD8 Antigen
41%
Cavernous Sinus Thrombosis
41%
Galcanezumab
41%
Magnetic Resonance Imaging
34%
Postoperative Pain
32%
Emotional Stress
30%
Depersonalization
30%
Odds Ratio
30%
Bacterial Meningitis
28%
Triptan Derivative
27%
Meningoencephalitis
27%
Glioblastoma
27%
Substance Use Disorder
25%
Transformed Migraine
24%
Episodic Migraine
24%
Oncology
24%
Metronidazole
24%
Infratemporal Fossa
24%
Lumbar Puncture
23%
Acute Stress
20%
Medical History
20%
Neurologic Disease
20%
Autoimmunity
20%
Mental Health
20%
Emotional Disorder
20%
Sensation
20%
Molecular Diagnosis
20%
National Institutes of Health Stroke Scale
18%
Substance Abuse
17%
Mental Disorder
17%
Pregnant Woman
17%
Cross Sectional Study
17%
Adjuvant Therapy
16%
Overall Survival
16%
Anticoagulation
16%
Vascular Neurology
16%
Diseases
15%
Selective Serotonin Reuptake Inhibitor
13%
Reversible Cerebral Vasoconstriction Syndrome
13%
Hemiplegic Migraine
13%
Comorbidity
13%
Brain Ventriculitis
13%
Stupor
13%
Anisocoria
13%
Craniotomy
13%
Methylation
13%
Promoter Region
13%
Multiplex Ligation Dependent Probe Amplification
13%
Oligoastrocytoma
13%
Brain Biopsy
13%
Disorientation
13%
Headache and Facial Pain
12%
Emergency Department
12%
Maxillary Artery
12%
Maxillary Sinus
12%
Pharmacogenomics
10%
Pharmacokinetic
10%
Neuroscience
Mental Disorder
82%
Brain Ischemia
82%
Neuroscience
51%
Anticonvulsant
45%
Longitudinal Study
41%
Headache
41%
Posttraumatic Stress Disorder
41%
Mild Cognitive Impairment
41%
Phenytoin
41%
Cytochrome P450 2C9
41%
Glucagon-Like Peptide-1 Agonist
41%
Glucagon-Like Peptide-1
41%
Cerebrovascular Accident
41%
Subarachnoid Hemorrhage
41%
Neuropsychiatric Symptom
41%
Neurotrauma
41%
Traumatic Brain Injury
41%
Astrocytoma
41%
Multiplex Ligation-Dependent Probe Amplification
41%
Methylation
41%
Pterygopalatine Fossa
41%
Promoter Region
41%
Galcanezumab
41%
Substance Abuse
30%
Infratemporal Fossa
24%
Risk Factor
23%
Dideoxynucleotide Sequencing
20%
Epidermal Growth Factor Receptor
20%
Oligodendroglioma
20%
IDH2
20%
Intracranial Tumor
20%
Maxillary Sinus
12%
Maxillary Artery
12%
Hyperglycemia
11%
Psychostimulant
10%
Dopamine Release
10%
Blood Brain Barrier
10%
Hydrocephalus
10%
Psychiatry
10%
Behavior (Neuroscience)
10%
Pharmacokinetics
10%
Central Nervous System
10%
Glaucoma
10%
Migraine
8%
Glasgow Coma Scale
8%
Skull Base
8%
Pterygopalatine Ganglion
8%
Infraorbital Nerve
8%
Electric Shock
6%
Comorbidity
5%
Hematoma
5%
Cohort Analysis
5%
Cerebral Edema
5%
Computed Tomography
5%
Uveitis
5%
Scleritis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Headache
98%
Anticonvulsive Agent
82%
Migraine
58%
Prevalence
52%
Ovary Polycystic Disease
41%
Mild Cognitive Impairment
41%
Primary Headache
41%
Monoclonal Antibody
41%
Triptan Derivative
41%
Glucagon Like Peptide 1 Receptor Agonist
41%
Glucagon-Like Peptide-1
41%
Cavernous Sinus Thrombosis
41%
Fusobacterium nucleatum
41%
Galcanezumab
41%
Episodic Migraine
24%
Transformed Migraine
24%
Hemiplegic Migraine
20%
Selective Serotonin Reuptake Inhibitor
20%
Reversible Cerebral Vasoconstriction Syndrome
20%
Cerebrovascular Accident
20%
Cross-Sectional Study
11%
Aneurysm
10%
Psychostimulant
10%
Drug Dependence
10%
Blood-Brain Barrier
10%
Insulin Resistance
10%
Venous Thromboembolism
10%
Pharmacokinetics
10%
Clinical Study
10%
Pharmacogenomics
10%
Observational Study
10%
Calcitonin Gene Related Peptide
8%
Diseases
8%
Diplopia
8%
Anaerobic Bacterium
8%
Fusobacterium
8%
Photophobia
8%
Cranial Nerve Paralysis
8%
Anaerobe
8%
Abscess
8%
Cigarette Smoking
8%
Fusobacterium necrophorum
8%
Pentetrazole
6%
Phenobarbital
6%
Electric Shock
6%
Provocation Test
6%
Sodium Valproate
6%
Controlled Clinical Trial
6%
Constipation
6%
Oral Administration
5%
Comorbidity
5%
Headache and Facial Pain
5%
Lacosamide
5%
Pregabalin
5%
Tiagabine
5%
Felbamate
5%
Vigabatrin
5%
Gabapentin
5%
Topiramate
5%
Rufinamide
5%
Levetiracetam
5%
Lamictal
5%
Oxcarbazepine
5%
Zonisamide
5%
Cohort Study
5%